Benzo[c]phenanthridine Compounds Inhibit FtsZ Polymerization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The emergence of multidrug-resistant bacterial pathogens, such as MRSA, has highlighted the need for new antibiotics with novel mechanisms of action that can effectively inhibit bacterial cell division by targeting the FtsZ protein, as current antimicrobials are inadequate and often toxic.
Innovation Solution
Development of compounds that inhibit FtsZ polymerization and Z-ring formation by competitively binding to the GTP binding site of the FtsZ protein, preventing bacterial cell cytokinesis, using specific benzo[c]phenanthridine derivatives with enhanced van der Waals interactions and hydrogen bonding.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current antimicrobials are used to treat multidrug-resistant bacterial pathogens, then treatment effectiveness is reduced, but toxicity increases
Solution Approach 1:
The invention segments the antibacterial function from existing toxic antimicrobials by identifying and targeting a specific bacterial protein (FtsZ) that is essential for cell division. By focusing on this specific target rather than using broad-spectrum antimicrobials, the treatment achieves effectiveness against MDR pathogens while reducing unnecessary toxicity to host cells.
Solution Approach 2:
The patent introduces new chemical compounds as intermediaries that specifically bind to the FtsZ protein. These compounds act as mediators between the treatment goal (inhibiting bacterial division) and the target (FtsZ protein), providing a more selective and less toxic approach compared to traditional antimicrobials that directly damage bacterial cells through non-specific mechanisms.
2Reliability
If traditional antibiotics are used to treat MDR infections, then resistance pathways are activated, but treatment options are limited
Solution Approach 1:
Instead of trying to overcome resistance to traditional antibiotics, the invention inverts the approach by completely changing the target. Rather than targeting cell wall synthesis, protein synthesis, or DNA replication (traditional antibiotic targets), the patent targets FtsZ polymerization, a fundamentally different mechanism that bacteria use for cell division. This inversion bypasses existing resistance pathways.
Solution Approach 2:
The patent changes the fundamental parameter of the target mechanism from traditional antibiotic targets to FtsZ GTPase activity and polymerization. By changing this critical parameter, the new compounds operate through a novel mechanism of action that is not subject to resistance developed against conventional antibiotics, thereby expanding treatment versatility against MDR pathogens.
3Reliability
If FtsZ inhibition is enhanced to prevent bacterial cell division, then antimicrobial effectiveness increases, but selectivity against host cells must be maintained
Solution Approach 1:
The patent applies local quality by designing compounds with specific structural features that match the binding site of FtsZ protein. The compounds contain functional groups and spatial arrangements that specifically interact with amino acid residues in the FtsZ GTP binding site, ensuring high affinity and selectivity for the bacterial target while avoiding interaction with eukaryotic cellular components.
Solution Approach 2:
The invention creates compounds that copy or mimic the transition state of GTP binding to FtsZ, or the structure of natural FtsZ ligands. By copying the essential interaction features without being the actual substrate (GTP), the compounds achieve strong competitive inhibition while maintaining selectivity, as the copied structure is optimized specifically for bacterial FtsZ rather than eukaryotic proteins.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds effectively inhibit FtsZ polymerization and Z-ring formation, thereby preventing bacterial cell division, offering a potential solution for treating multidrug-resistant infections with reduced toxicity.
Implementation Method 1
benzo[c]phenanthridines (B[c]P compounds) prevent GTPase activity and FtsZ polymerization by competitively inhibiting the binding of GTP to FtsZ
Implementation Method 2
using specific benzo[c]phenanthridine derivatives with enhanced van der Waals interactions and hydrogen bonding
Implementation Method 3
using specific benzo[c]phenanthridine derivatives with enhanced van der Waals interactions and hydrogen bonding
Data Source
AI summary
The present invention provides compounds of formula I: formula (I) wherein X1-X4 and R1-R12 have any of the values defined in the specification, as well as salts and prodrugs thereof, which inhibit major molecular mechanisms associated with bacterial cell division and proliferation so as to be useful for the treatment and/or prevention of bacterial infections. The invention also provides compositions comprising these compounds as well as methods for using these compounds to inhibit bacterial cell division and proliferation and to treat bacterial infections.